...
首页> 外文期刊>Ageing Research Reviews >Peroxisome proliferator-activated receptor agonists in a battle against the aging kidney
【24h】

Peroxisome proliferator-activated receptor agonists in a battle against the aging kidney

机译:过氧化物酶体增殖物激活的受体激动剂与衰老的肾脏作斗争

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

As aging is a complex phenomenon characterized by intraindividual and interindividual diversities in the maintenance of the homeostatic condition of cells and tissues, changes in renal function are not uniform and depend on associated diseases and environmental factors. Multiple studies have investigated the possible underlying mechanisms of age-related decline in kidney function. Evolutionary, molecular, cellular and systemic theories have been postulated to explain the primary disease independent age-related changes and adaptive responses. As peroxisome proliferator-activated receptors (PPARs) are involved in a broad spectrum of biological processes, PPAR activation might have an effect on the prevention of cell senescence. In this review, we will focus on the experimental and clinical evidence of PPAR agonists in a battle against the aging kidney.
机译:由于衰老是一种复杂的现象,其特征是维持细胞和组织体内平衡状态时个体内和个体间的差异,因此肾功能的变化并不统一,并取决于相关疾病和环境因素。多项研究调查了与年龄相关的肾功能下降的潜在机制。已经提出了进化论,分子论,细胞论和系统论来解释原发疾病无关的年龄相关变化和适应性反应。由于过氧化物酶体增殖物激活受体(PPAR)参与了广泛的生物过程,因此PPAR激活可能对防止细胞衰老有影响。在这篇综述中,我们将重点研究PPAR激动剂在对抗衰老的肾脏方面的实验和临床证据。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号